Delivery Order SPE2DB24D2205-SPE2DB25FEBSL
Award Date
4/30/25
Potential Completion Date
5/1/25
Potential Value
$17K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,064.40, is for the delivery of 4,568,032,429 units of the BOOSTRIX TDAP vaccine syringe (0.5 mL). The contract is a firm fixed-price, non-set-aside delivery order with an ultimate completion date of April 28, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,568,246,581 units of the BOOSTRIX TDAP vaccine syringe (0.5 mL). The contract has a firm fixed price of $3,647.74 and a period of performance through May 15, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999.00, which...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,568,150,456 units of the BOOSTRIX TDAP vaccine syringe (0.5mL). The contract has a ceiling value of $3,546.48 and is a firm fixed-price, non-set-aside contract with a period of performance through May 7, 2025. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) valued at $999,999,999.00 with the DLA Troop...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the provision of 4,560,911,316 units of the BOOSTRIX TDAP Vaccine Syringe 0.5mL. The contract has a firm fixed price of $3,347.23 and a completion date of May 12, 2023. This delivery order is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC serves as a...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,566,446,070 units of the BOOSTRIX TDAP vaccine syringe (0.5 ml). The firm-fixed-price contract is valued at $1,053.96 and has an ultimate completion date of November 18, 2024. The contract is not designated as a set-aside. AmerisourceBergen, a for-profit organization registered in the System for Award Management (SAM.gov), holds a...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,568,369,386 units of the BOOSTRIX TDAP VACCINE SYRINGE 0.5ML product. The contract has a firm-fixed price of $2,890.36 and a completion date of May 29, 2025. Amerisourcebergen Drug Corp is the prime contractor, and there is no set-aside designation for this contract....
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $21,044.78 firm fixed-price contract is for the delivery of 4,568,115,914 units of the BOOSTRIX TDAP VACCINE SYRINGE 0.5ML. The contract has an ultimate completion date of May 5, 2025 and was awarded on May 2, 2025. This delivery order is associated with a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Boostrix TDAP vaccine syringes, with a ceiling value of $1,596.60 and a period of performance through May 2025. The contract is a firm-fixed-price delivery order, with no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,612.30 firm fixed-price contract is for the delivery of BOOSTRIX TDAP vaccine syringes, 0.5 ml, with a performance period ending on May 7, 2025. This delivery order is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) between AmerisourceBergen and DLA Troop Support Medical, which enables...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Boostrix TDAP vaccine syringes, 0.5mL, with a firm fixed price of $1,330.50 and a completion date of June 17, 2025. The contract is not set aside and is a delivery order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999.00 that AmerisourceBergen holds with...